AHR and fatty liver disease: The activation of ERK promoted AHR expression, then AHR directly binded to the promoter regions of the key fatty acid oxidation enzymes ACOX 1 and CPT1A to transcribe and activate their expression and then achieved normal fatty acid oxidation function, thus inhibiting hepatic steatosis (Han et al., 2021).